Event
ELRIG Drug Discovery
đź“… Date: October 21-22, 2025Â
đź“ŤÂ Location: Liverpool, UK
Silvia Cainarca, Scientific OfficerÂ
Alessio Perotti, Automation Manager – HTS automation
Katie Headland, Senior Director
Business Development UK
Rebecca Mary Steele, Manager – Marketing and Communication
Axxam at ELRIG Drug Discovery 2025 in Liverpool
Axxam is thrilled to attend ELRIG Drug Discovery 2025 in Liverpool, UK, on October 21–22. This premier life-science event gathers scientists, biotech, pharma, and technology providers across Europe. Our presence will highlight our scientific and automation strengths. Four Axxam team members — Silvia Cainarca (Scientific Officer), Alessio Perotti (Automation Manager), Katie Headland (Senior BD Director, UK), and Rebecca Steele (Marketing & Communications Manager) — will be on site to represent our capabilities and engage with attendees.
Presentations by Silvia & Alessio: Showcasing Axxam’s science and technology
On Tuesday, October 21, two of our scientists will take the stage to share recent advances from Axxam’s discovery programs:
🔹 Silvia – “Harnessing iPSC technology to enable disease-relevant assays for neurodegenerative drug discovery”
đź—“ Tuesday, October 21
🕦 11:40 AM – 12:10 PM
đź“Ť Auditorium 3
🔹 Alessio – “Bridging the channel: Complementing ion channel kinetics screening with orthogonal automated patch clamp”
đź—“ Tuesday, October 21
🕓 4:30 PM – 5:30 PM
đź“Ť Auditorium 1
These talks highlight our scientific commitment to iPSC-based models, ion channel screening, and automation, demonstrating how we combine advanced technologies with biological relevance to enhance drug discovery outcomes.
Our Expertise and why meet us
At ELRIG Drug Discovery, visitors can explore how Axxam integrates biology, automation, and functional screening to deliver meaningful data and reproducible results.
Moreover, our experts will be available to discuss:
Disease-relevant iPSC models for neurodegenerative research
Electrophysiology and automated patch-clamp platforms
Ion channel kinetics screening and orthogonal assays
Automation workflows that streamline discovery campaigns
Tailored collaboration models for biotech and pharma teams
Through these capabilities, Axxam helps partners turn early concepts into robust discoveries, efficiently and with confidence.
📍 Let’s meet in Liverpool
Will you attend ELRIG Drug Discovery 2025? Let’s meet in Liverpool to discuss how our technologies and expertise can support your next program.
Contact us to schedule a meeting with Silvia, Alessio, Katie, or Rebecca — and discover how Axxam’s biology-driven approach can empower your discovery goals.